|
|
|
Weekly Market: Markets tumble 2% in first week of February series
|
|
Saturday, February 7, 2015 |
| | | Market Commentary | | | Markets tumble 2% in first week of February series | | Indian stock markets closed the week on a weak note led by unsupportive domestic cues as heavyweights declined after profit booking dampened the market sentiments | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, February 06, 2015 where key benchmark indices edged lower in the week ended Friday, 6 February 2015, as key index heavyweights ICICI Bank, HDFC Bank and Reliance Industries (RIL) declined.
The barometer index, the S&P BSE Sensex settled below the psychological 29,000 level after gyrating above and below that level during the week. The sentiment was weak with the market logging declines on all the five trading sessions of the week.
In the week ended Friday, 6 February 2015, the 30-share S&P BSE Sensex lost 465.04 points or 1.59% to settle at 28,717.91. The 50-unit CNX Nifty lost 147.85 points or 1.68% to settle at 8,661.05.
The S&P BSE Mid-Cap index fell 247.91 points or 2.31% to settle at 10,490.68. The S&P BSE Small-Cap index fell 251.92 points or 2.22% to settle at 11,077.34. The fall in these two indices was higher than the Sensex's decline in percentage terms.
Weekly market trend from February 02 - February 06:
Feb 02- Trading for the week and the month began on a subdued note on Monday. The S&P BSE Sensex fell 60.68 points or 0.21% to settle at 29,122.27, its lowest closing level since 22 January 2015.
Feb 03- Amid a rebound in global crude oil prices, key equity benchmark indices in India edged lower in what was a volatile trading session on Tuesday. The S&P BSE Sensex fell 122.13 points or 0.42% to settle at 29,000.14, its lowest closing level since 21 January 2015.
Feb 04- Taking cues from weakness in European stocks, key equity benchmark indices in India edged lower on Wednesday. The S&P BSE Sensex lost 117.03 points or 0.4% to settle at 28,883.11, its lowest closing level since 20 January 2015.
Feb 05- Amid intense volatility during the second half of the trading session, key benchmark indices registered small losses at close on Thursday. The S&P BSE Sensex fell 32.14 points or 0.11% to settle at 28,850.97, its lowest closing level since 20 January 2015.
 Feb 06- Pharma and bank stocks led decline as key benchmark indices edged lower on the last trading session of the week on Friday. The S&P BSE Sensex shed 133.06 points or 0.46% to settle at 28,717.91, its lowest closing level since 19 January 2015.
Global indices:
Global Indices closed mixed for the week where Dow Jones up 3.84%, Nasdaq rose 2.36% and CAC40 was up by 1.88%. Top Losers: Shanghai Composite down 4.19% and Nikkei down 0.15%
 Sectoral and stock screening:
Top gainers: S&P BSE IT up 3.98%, S&P BSE TECk up 2.72% and S&P BSE FMCG up 0.18%
Top losers: S&P BSE Power down 5.40%, S&P BSE Bankex down 5.20% and S&P BSE Auto up 4.67%
| | Looking at the 'A' group stocks, the top three gainers of the week were - PMC Fincorp up by 27.29%, Kaveri Seed Company up by 19.07% and Future Retail up by 18.86%
Top three losers of the week were - Crompton Greaves down by 16.10%, JSW Energy down by 15.45% and IOB down by 12.46%
FII/MF activity:
The foreign institutional investors (FIIs) have been the net sellers of the Indian stocks to the tune of Rs623.30 crore whereas the domestic investors bought Indian shares worth a net of Rs546.90 crore as on February 05, 2015 | | TOP MOVERS (GROUP A) |  | | | | | | | | | | Kaveri Seed Company | 873.45 | 19.07 | | | Future Retail | 138.95 | 18.86 | | | | | Crompton Greaves | 159.15 | -16.10 | | | | | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 21,197 | 4,364 | | | | | | | | | | | | | Data as on February 05, 2015 | | | | Market Outlook for the coming week!
In the coming week, domestic and global macro economic data, outcome of Delhi Assembly elections, Q3 results of India Inc., trend in global markets, investment by foreign portfolio investors (FPIs) and domestic institutional investors (DIIs), the movement of rupee against the dollar and crude oil price movement will dictate trend on the bourses.
Domestic market will on Monday, 9 February 2015 react to the nonfarm payroll data for January 2015 released by the US government on Friday, 6 February 2015.
On Monday, 9 February 2015, the government will release advance estimates of GDP for 2014-15, as well as for the first three quarters of the current financial year - on the basis of the revised methodology.
Among macro economic data, the government will release index of industrial production (IIP) data for December 2014 on Thursday, 12 February 2015. On the same day, the government will release data for the annual rate of inflation based on the combined consumer price indices (CPI) for urban and rural India in January 2015.
Among other global economic events to be watched out for during the week include the G-20 finance ministers and central bank governors meet in Istanbul for a two-day summit which begins on Monday, 9 February 2015. | | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 3:37 AM  |
|
|
|
|
|
